NKTR logo

Nektar Therapeutics (NKTR) Gross profit

Annual gross profit:

$66.47M+$12.99M(+24.30%)
December 31, 2024

Summary

  • As of today (September 16, 2025), NKTR annual gross profit is $66.47 million, with the most recent change of +$12.99 million (+24.30%) on December 31, 2024.
  • During the last 3 years, NKTR annual gross profit has fallen by -$715.00 thousand (-1.06%).
  • NKTR annual gross profit is now -94.29% below its all-time high of $1.16 billion, reached on December 31, 2018.

Performance

NKTR Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

quarterly gross profit:

$10.96M+$927.00K(+9.24%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR quarterly gross profit is $10.96 million, with the most recent change of +$927.00 thousand (+9.24%) on June 30, 2025.
  • Over the past year, NKTR quarterly gross profit has dropped by -$2.79 million (-20.28%).
  • NKTR quarterly gross profit is now -98.99% below its all-time high of $1.08 billion, reached on June 30, 2018.

Performance

NKTR quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM gross profit:

$61.88M-$2.79M(-4.31%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR TTM gross profit is $61.88 million, with the most recent change of -$2.79 million (-4.31%) on June 30, 2025.
  • Over the past year, NKTR TTM gross profit has increased by +$6.71 million (+12.17%).
  • NKTR TTM gross profit is now -95.40% below its all-time high of $1.35 billion, reached on June 30, 2018.

Performance

NKTR TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

NKTR Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.3%-20.3%+12.2%
3 y3 years-1.1%-33.5%-16.9%
5 y5 years-21.9%-74.5%-55.7%

NKTR Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.1%+24.3%-48.3%+9.2%-16.9%+12.7%
5 y5-year-46.5%+24.3%-74.5%+9.2%-55.8%+12.7%
alltimeall time-94.3%>+9999.0%-99.0%+147.5%-95.4%+180.2%

NKTR Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.96M(+9.2%)
$61.88M(-4.3%)
Mar 2025
-
$10.03M(-52.7%)
$64.67M(-4.5%)
Dec 2024
$66.47M(+24.3%)
$21.20M(+7.7%)
$67.74M(+7.3%)
Sep 2024
-
$19.69M(+43.2%)
$63.15M(+14.5%)
Jun 2024
-
$13.75M(+4.9%)
$55.17M(+0.4%)
Mar 2024
-
$13.11M(-21.1%)
$54.92M(-2.5%)
Dec 2023
$53.48M(-15.0%)
$16.60M(+41.7%)
$56.35M(+1.5%)
Sep 2023
-
$11.71M(-13.3%)
$55.54M(-11.1%)
Jun 2023
-
$13.51M(-7.1%)
$62.48M(-4.5%)
Mar 2023
-
$14.53M(-8.0%)
$65.45M(-7.1%)
Dec 2022
$62.92M(-6.4%)
$15.79M(-15.3%)
$70.42M(-4.2%)
Sep 2022
-
$18.65M(+13.3%)
$73.48M(-1.3%)
Jun 2022
-
$16.47M(-15.6%)
$74.43M(-5.3%)
Mar 2022
-
$19.51M(+3.5%)
$78.63M(+2.1%)
Dec 2021
$67.19M(-45.9%)
$18.85M(-3.9%)
$77.01M(-0.4%)
Sep 2021
-
$19.61M(-5.1%)
$77.30M(-5.9%)
Jun 2021
-
$20.66M(+15.5%)
$82.16M(-21.4%)
Mar 2021
-
$17.89M(-6.5%)
$104.57M(-20.3%)
Dec 2020
$124.17M(+45.9%)
$19.14M(-21.8%)
$131.19M(-6.2%)
Sep 2020
-
$24.46M(-43.2%)
$139.92M(+0.1%)
Jun 2020
-
$43.07M(-3.2%)
$139.75M(+21.6%)
Mar 2020
-
$44.51M(+59.7%)
$114.97M(+23.3%)
Dec 2019
$85.10M(-92.7%)
$27.87M(+14.7%)
$93.24M(-4.6%)
Sep 2019
-
$24.29M(+32.8%)
$97.73M(+1.4%)
Jun 2019
-
$18.30M(-19.7%)
$96.42M(-91.7%)
Mar 2019
-
$22.78M(-29.6%)
$1.16B(-0.7%)
Dec 2018
$1.16B(+330.6%)
$32.37M(+40.8%)
$1.17B(-4.4%)
Sep 2018
-
$22.98M(-97.9%)
$1.22B(-9.2%)
Jun 2018
-
$1.08B(+3349.6%)
$1.35B(+362.2%)
Mar 2018
-
$31.37M(-63.4%)
$291.34M(+4.6%)
Dec 2017
$270.19M(+112.3%)
$85.71M(-41.8%)
$278.56M(+24.5%)
Sep 2017
-
$147.25M(+445.4%)
$223.70M(+111.5%)
Jun 2017
-
$27.00M(+45.2%)
$105.75M(+1.9%)
Mar 2017
-
$18.60M(-39.7%)
$103.81M(-23.2%)
Dec 2016
$127.27M(-33.1%)
$30.85M(+5.3%)
$135.22M(-0.1%)
Sep 2016
-
$29.30M(+16.9%)
$135.38M(-15.0%)
Jun 2016
-
$25.06M(-49.9%)
$159.27M(+8.8%)
Mar 2016
-
$50.01M(+61.3%)
$146.34M(-25.6%)
Dec 2015
$190.16M(+14.9%)
$31.01M(-41.7%)
$196.68M(+9.9%)
Sep 2015
-
$53.19M(+338.6%)
$178.93M(-28.3%)
Jun 2015
-
$12.13M(-87.9%)
$249.39M(-4.3%)
Mar 2015
-
$100.36M(+657.2%)
$260.67M(+51.4%)
Dec 2014
$165.54M(+60.9%)
$13.25M(-89.3%)
$172.17M(-4.9%)
Sep 2014
-
$123.65M(+428.3%)
$181.11M(+71.7%)
Jun 2014
-
$23.41M(+97.3%)
$105.49M(-4.9%)
Mar 2014
-
$11.86M(-46.5%)
$110.93M(+0.5%)
Dec 2013
$102.87M(+102.7%)
$22.19M(-53.8%)
$110.41M(+8.2%)
Sep 2013
-
$48.03M(+66.5%)
$102.08M(+56.5%)
Jun 2013
-
$28.85M(+154.4%)
$65.23M(+23.4%)
Mar 2013
-
$11.34M(-18.1%)
$52.86M(+4.1%)
Dec 2012
$50.76M(+2.4%)
$13.86M(+23.9%)
$50.76M(+264.2%)
Sep 2012
-
$11.18M(-32.1%)
$13.94M(-323.5%)
Jun 2012
-
$16.48M(+78.3%)
-$6.24M(-86.4%)
Mar 2012
-
$9.24M(-140.2%)
-$45.80M(-40.7%)
Dec 2011
$49.59M(-62.8%)
-$22.97M(+155.6%)
-$77.18M(+303.4%)
Sep 2011
-
-$8.99M(-61.1%)
-$19.13M(-188.8%)
Jun 2011
-
-$23.08M(+4.2%)
$21.54M(-73.8%)
Mar 2011
-
-$22.14M(-163.1%)
$82.29M(-38.3%)
DateAnnualQuarterlyTTM
Dec 2010
$133.37M(+225.4%)
$35.08M(+10.7%)
$133.37M(+4.7%)
Sep 2010
-
$31.68M(-15.9%)
$127.38M(+27.1%)
Jun 2010
-
$37.67M(+30.2%)
$100.23M(+53.5%)
Mar 2010
-
$28.94M(-0.5%)
$65.31M(+59.4%)
Dec 2009
$40.98M(-27.5%)
$29.08M(+541.7%)
$40.98M(+36.4%)
Sep 2009
-
$4.53M(+64.4%)
$30.06M(-13.7%)
Jun 2009
-
$2.76M(-40.2%)
$34.83M(-23.1%)
Mar 2009
-
$4.61M(-74.6%)
$45.30M(-5.4%)
Dec 2008
$56.52M(-55.0%)
$18.16M(+95.2%)
$47.88M(-32.8%)
Sep 2008
-
$9.30M(-29.7%)
$71.22M(-21.3%)
Jun 2008
-
$13.23M(+83.9%)
$90.54M(-12.8%)
Mar 2008
-
$7.20M(-82.7%)
$103.84M(-16.9%)
Dec 2007
$125.54M(+31.3%)
$41.49M(+44.9%)
$124.90M(+26.6%)
Sep 2007
-
$28.63M(+7.9%)
$98.63M(+1.9%)
Jun 2007
-
$26.53M(-6.1%)
$96.75M(+4.7%)
Mar 2007
-
$28.26M(+85.7%)
$92.41M(+11.7%)
Dec 2006
$95.59M(+11.1%)
$15.21M(-43.1%)
$82.75M(-6.0%)
Sep 2006
-
$26.75M(+20.5%)
$88.01M(-2.8%)
Jun 2006
-
$22.19M(+19.3%)
$90.51M(+7.0%)
Mar 2006
-
$18.60M(-9.1%)
$84.62M(-1.6%)
Dec 2005
$86.08M(-4.9%)
$20.47M(-30.0%)
$85.99M(-4.3%)
Sep 2005
-
$29.25M(+79.4%)
$89.85M(+7.4%)
Jun 2005
-
$16.30M(-18.3%)
$83.69M(-5.1%)
Mar 2005
-
$19.96M(-18.0%)
$88.20M(+3.1%)
Dec 2004
$90.55M(+3.6%)
$24.33M(+5.4%)
$85.55M(+7.7%)
Sep 2004
-
$23.09M(+10.9%)
$79.42M(+0.3%)
Jun 2004
-
$20.81M(+20.2%)
$79.16M(-2.6%)
Mar 2004
-
$17.32M(-4.8%)
$81.26M(-2.9%)
Dec 2003
$87.36M(+25.9%)
$18.20M(-20.3%)
$83.72M(+1.4%)
Sep 2003
-
$22.83M(-0.3%)
$82.57M(+8.2%)
Jun 2003
-
$22.91M(+15.8%)
$76.33M(+9.3%)
Mar 2003
-
$19.78M(+16.1%)
$69.83M(-1.2%)
Dec 2002
$69.41M(+97.4%)
$17.04M(+2.7%)
$70.67M(+31.0%)
Sep 2002
-
$16.59M(+1.1%)
$53.95M(+10.5%)
Jun 2002
-
$16.42M(-20.4%)
$48.84M(+50.6%)
Mar 2002
-
$20.62M(+6404.1%)
$32.42M(+174.7%)
Dec 2001
$35.16M(>+9900.0%)
$317.00K(-97.2%)
$11.80M(+2.8%)
Sep 2001
-
$11.48M(>+9900.0%)
$11.48M(>+9900.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2000
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 1999
-
$0.00(0.0%)
$6.68M(-36.7%)
Dec 1998
$0.00(0.0%)
$0.00(0.0%)
$10.54M(0.0%)
Sep 1998
-
$0.00(-100.0%)
$10.54M(0.0%)
Jun 1998
-
$6.68M(+72.8%)
$10.54M(+172.8%)
Mar 1998
-
$3.87M(-5.7%)
$3.87M(+68.0%)
Dec 1997
$0.00(0.0%)
-
-
Dec 1996
$0.00(0.0%)
-
-
Dec 1995
$0.00(0.0%)
-
-
Dec 1994
$0.00
$4.10M(-920.0%)
$2.30M(-227.8%)
Sep 1994
-
-$500.00K(-28.6%)
-$1.80M(+38.5%)
Jun 1994
-
-$700.00K(+16.7%)
-$1.30M(+116.7%)
Mar 1994
-
-$600.00K
-$600.00K

FAQ

  • What is Nektar Therapeutics annual gross profit?
  • What is the all time high annual gross profit for Nektar Therapeutics?
  • What is Nektar Therapeutics annual gross profit year-on-year change?
  • What is Nektar Therapeutics quarterly gross profit?
  • What is the all time high quarterly gross profit for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly gross profit year-on-year change?
  • What is Nektar Therapeutics TTM gross profit?
  • What is the all time high TTM gross profit for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM gross profit year-on-year change?

What is Nektar Therapeutics annual gross profit?

The current annual gross profit of NKTR is $66.47M

What is the all time high annual gross profit for Nektar Therapeutics?

Nektar Therapeutics all-time high annual gross profit is $1.16B

What is Nektar Therapeutics annual gross profit year-on-year change?

Over the past year, NKTR annual gross profit has changed by +$12.99M (+24.30%)

What is Nektar Therapeutics quarterly gross profit?

The current quarterly gross profit of NKTR is $10.96M

What is the all time high quarterly gross profit for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly gross profit is $1.08B

What is Nektar Therapeutics quarterly gross profit year-on-year change?

Over the past year, NKTR quarterly gross profit has changed by -$2.79M (-20.28%)

What is Nektar Therapeutics TTM gross profit?

The current TTM gross profit of NKTR is $61.88M

What is the all time high TTM gross profit for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM gross profit is $1.35B

What is Nektar Therapeutics TTM gross profit year-on-year change?

Over the past year, NKTR TTM gross profit has changed by +$6.71M (+12.17%)
On this page